{"id":103280,"date":"2024-02-01T06:00:44","date_gmt":"2024-02-01T11:00:44","guid":{"rendered":"https:\/\/www.send2press.com\/wire\/?p=103280"},"modified":"2024-01-31T20:03:51","modified_gmt":"2024-02-01T01:03:51","slug":"bioaustinctx-adds-cindy-walkerpeach-and-ryan-hawkins-to-the-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.send2press.com\/wire\/bioaustinctx-adds-cindy-walkerpeach-and-ryan-hawkins-to-the-board-of-directors\/","title":{"rendered":"BioAustinCTX Adds Cindy WalkerPeach and Ryan Hawkins to the Board of Directors"},"content":{"rendered":"

AUSTIN, Texas, Feb. 1, 2024 (SEND2PRESS NEWSWIRE) — BioAustinCTX, Central Texas\u2019 Life Science industry organization, announced today the appointment of Cindy WalkerPeach, PhD and Ryan Hawkins to its Board of Directors.<\/p>\n

\"BioAustinCTX
Image Caption: BioAustinCTX – Central Texas.<\/em><\/p>\n

Cindy WalkerPeach has been involved in the Central Texas life science ecosystem since 1996, having relocated to Austin to join a bioscience startup. She currently leads the development of the Nexxus Project at the University of Texas at Austin and serves on the national faculty for the National Institutes of Health (NIH) and National Science Foundation (NSF) Innovation Corps (I-Corps) Programs. Prior to UT, she was the Chief Product Development Officer at the Cancer Prevention & Research Institute of Texas (CPRIT). Prior to government service, Dr. WalkerPeach has 20+ years experience in the biotechnology sector as a member of several life science company management teams, all located in Central Texas, where she led product development and commercial operations.<\/p>\n

\u201cIt\u2019s an exciting time, as Central Texas continues its development into a first-class life sciences hub. BioAustinCTX has been, and continues to be, a critical component for connectivity within the region,\u201d said WalkerPeach.<\/p>\n

Ryan Hawkins is an accomplished biopharmaceutical leader with 25 years\u2019 experience in the life sciences. Ryan serves as the Chief Operating Officer at Disruption Labs, a plant-derived delivery technology company serving the nutraceutical industry. Prior to joining Disruption Labs, Ryan was responsible for Technical Operations at Molecular Templates, a clinical stage biotechnology company and spent 20 years in the biopharmaceutical contract development and manufacturing industry.<\/p>\n

\u201cAll of the ingredients are present in Austin and Central Texas to have thriving, dynamic life science community that creates benefits beyond the advertised value proposition. Being a part of creating our secret sauce recipe that attracts people, conversation, companies, and community building is very exciting. As a member of the BioAustinCTX board, I look forward to unlocking our community\u2019s potential in this regard,\u201d said Hawkins.<\/p>\n

\u201cCindy and Ryan bring tremendous experience and knowledge and we look forward to the energy and expertise they will bring to advancing BioAustinCTX\u2019s pivotal role in growing the life science ecosystem in Central Texas,\u201d said Scott Collins, Board of Directors President.<\/p>\n

About BioAustinCTX:<\/strong><\/p>\n

BioAustinCTX is a nonprofit organization based in Austin, Texas focused on advancing the life science industry in the Central Texas Region. Visit BioAustinCTX for more information: https:\/\/bioaustinctx.com\/<\/a>.<\/p>\n

Media Contact:<\/strong><\/p>\n

Hilary Graham PhD<\/p>\n

operations@bioaustinctx.com<\/p>\n","protected":false},"excerpt":{"rendered":"

AUSTIN, Texas, Feb. 1, 2024 (SEND2PRESS NEWSWIRE) — BioAustinCTX, Central Texas’ Life Science industry organization, announced today the appointment of Cindy WalkerPeach, PhD and Ryan Hawkins to its Board of Directors. BioAustinCTX is a nonprofit organization based in Austin, Texas focused on advancing the life science industry in the Central Texas Region.<\/p>\n","protected":false},"author":9004,"featured_media":80385,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[602,12804,334,1,61,317,56,55],"tags":[16206],"class_list":["post-103280","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology-news","category-ap","category-austin-news","category-business-news","category-health-medical-news","category-career-news","category-non-profit-news","category-texas-news","tag-central-texas","has-post-title","has-post-date","no-post-category","no-post-tag","no-post-comment","has-post-author"],"acf":[],"views":3279,"_links":{"self":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/103280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/users\/9004"}],"replies":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/comments?post=103280"}],"version-history":[{"count":0,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/103280\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media\/80385"}],"wp:attachment":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media?parent=103280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/categories?post=103280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/tags?post=103280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}